Izotropic Corporation

Commercializing a Dedicated Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of Breast Cancers

Recent News

  • Mr. Alexander Tokman Joins Izotropic as Strategic Advisor

    Vancouver, British Columbia--(Newsfile Corp. - September 15, 2020) -  Izotropic Corporation ("Izotropic" or the "Company") (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) is pleased to announce the addition of Mr. Alexander Tokman as Strategic Advisor to the Company's growing advisory board. Mr. Tokman is a growth-driven executive leader with over 22 years of global, cross-functional profit and loss leadership, specializing in creating and commercializing new technology businesses in the Healthcare, Consumer Electronics and Semiconductor sectors for Fortune 100, technology Micro-Cap...

    2020-09-15 8:00 AM ET
  • Izotropic Engages MarketSmart Communications

    Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has entered into a consulting agreement with MarketSmart Communications Inc. (MarketSmart) to help build awareness of the company's corporate profile within the investment community.Established in 2002, MarketSmart has represented numerous successful public companies including SONA Nanotech Inc. (Symbol SONA), which has been an active client since February of this year. MarketSmart has...

    2020-08-31 8:00 AM ET
  • Izotropic Files Pre-Submission Application with U.S. FDA

    Vancouver, British Columbia--(Newsfile Corp. - August 18, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that it has filed a Pre-Submission Application with the U.S. Food and Drug Administration (FDA) marking the beginning of the market approval process for the Company's commercial Breast CT Imaging System. The Pre-Submission Application filing has been a highly anticipated event for the Company and is a major milestone for the inventors, stakeholders...

    2020-08-18 8:00 AM ET
  • Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design

    Vancouver, British Columbia--(Newsfile Corp. - July 8, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that it has engaged Dr. Craig Abbey, Ph.D., to develop and present proposed reader study designs to the FDA during the Company's pre-submission meeting for approval of its Breast CT Imaging System. Dr. Abbey has a Ph.D. in Applied Mathematics and currently holds a professional Researcher position at the University of California,...

    2020-07-08 3:01 AM ET
  • Izotropic Corporation Appoints Executive Vice President of Commercial Operations

    Vancouver, British Columbia--(Newsfile Corp. - July 6, 2020) -  Izotropic Corporation (CSE: IZO) (OTC PINK: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the appointment of John McGraw, Ph.D., as Executive Vice President of Commercial Operations.Dr. McGraw brings over 20 years of technology and business development experience spanning several medical device and healthcare-related market segments and has created and implemented successful strategies for the commercialization of new technologies in medical devices, imaging and laboratory diagnostics and therapeutics. He...

    2020-07-06 3:01 AM ET
  • Izotropic Begins FDA Approval Process

    Vancouver, British Columbia--(Newsfile Corp. - May 25, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has engaged company advisor and FDA Consultant, Anita Nosratieh Ph.D., to develop and manage the Company's application for FDA medical device approval of its dedicated Breast CT Imaging System. The first stage towards FDA approval is focused on developing a detailed pre-submission strategy and application, which will be managed by Nosratieh. Her extensive...

    2020-05-25 3:01 AM ET
  • FDA Consultant Joins Izotropic Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - May 20, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that Anita Nosratieh Ph.D., as a new member of the Company's Advisory Board. Nosratieh began her career as a lead reviewer at the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) where she worked with companies seeking approval of breast cancer screening and diagnostic devices. As lead reviewer, she...

    2020-05-20 3:01 AM ET
  • Izotropic Engages StarFish Medical for Design and Development of Commercial Breast CT Model

    Vancouver, British Columbia--(Newsfile Corp. - May 13, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has engaged StarFish Medical, Canada's largest medical device design, development and contract manufacturing company, to complete the final design and development of the Company's commercial breast CT model. StarFish Medical Founder and CEO Scott Phillips commented on the collaboration: "We have worked with numerous companies in the medical and breast imaging spaces. Izotropic...

    2020-05-13 3:01 AM ET